VERIFY RECORD
Hippocratic AI
3 of 6 claims verified
3 of 6 key claims verified, 2 thin, 1 plausible; headcount and revenue figures are gaps
Claims
- [verified]
Hippocratic AI raised $126 million in Series C funding at a $3.5 billion valuation (announced November 3, 2025), bringing total funding to $404 million.
Led by Avenir Growth with CapitalG, General Catalyst, Andreessen Horowitz, Kleiner Perkins and others participating.
- [verified]
Founded May 2023 by CEO Munjal Shah with a $50 million seed round co-led by General Catalyst and Andreessen Horowitz, to build a safety-focused healthcare LLM.
- [verified]
Marketed AI nursing agents at roughly $9/hour versus a roughly $90/hour cost for a human nurse (a 2024 positioning tied to the Nvidia GTC partnership).
Claim verified as a marketing/pricing comparison the company itself published, not as an audited cost figure. It drew criticism from nursing advocates over wage displacement framing.
- [plausible]
Partnerships with over 50 large health systems, payors, and pharma clients across 6 countries, and over 1,000 clinical use cases built, in the 15 months since commercialization.
Sourced to the company's own funding announcement; named customers (Universal Health Services, Cincinnati Children's Hospital Medical Center, WellSpan Health) are consistent with the claim but no independent third party has audited the full count.
- [thin]
Over 115 million clinical patient interactions completed with zero reported safety issues.
Single-source, self-reported safety claim from the company's own press release. No independent clinical safety audit or regulator statement found to corroborate 'zero safety issues.'
- [thin]
Hippocratic AI's model outperformed GPT-4 on 105 of 114 healthcare certification exams (exceeding by 5%+ on 74, by 10%+ on 43; e.g. NAPLEX +20.2%, NCLEX-RN +12.4%).
Company-run, self-administered benchmark at its own May 2023 launch; no independently published third-party replication of these exact scores was found.
Gaps
- Current headcount is unconfirmed and contradictory across third-party trackers: Tracxn cites ~312 (May 2026), LeadIQ ~268 (March 2026), Latka ~235, JobsByCulture ~264, RocketReach ~297. No authoritative company-disclosed figure was found.
- Revenue/ARR is unconfirmed: only a single third-party estimate (Latka, ~$15.8M ARR) was found, with no primary-source or audited figure to corroborate it.
- A widely repeated 'handles 8M+ patient calls a month' figure traces to a secondary aggregator (callsphere.ai blog) rather than a primary company or press disclosure, so it was not included as a verified or thin finding.
- No public revenue or valuation figure independent of the company's own Series C announcement was found (e.g. no independent audit of the $3.5B valuation).